EFFECTS OF HISTAMINE ON 5-HYDROXYTRYPTAMINERGIC NEURONAL-ACTIVITY IN THE RAT HYPOTHALAMUS

被引:20
作者
FLECKENSTEIN, AE
LOOKINGLAND, KJ
MOORE, KE
机构
[1] Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824
关键词
HISTAMINE; 5-HT; (5-HYDROXYTRYPTAMINE; SEROTONIN); MEPYRAMINE; ZOLANTIDINE; THIOPERAMIDE; METOPRINE;
D O I
10.1016/0014-2999(94)90367-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Effects of pharmacological manipulations which mimic or enhance histaminergic neuronal transmission were determined on the activity of 5-hydroxytryptaminergic neurons projecting to the hypothalamus of male rats. Intracerebroventricular administration of histamine decreased 5-hydroxytryptamine (5-HT) and increased 5-hydroxyindoleacetic acid (5-HIAA) concentrations in several hypothalamic nuclei; these effects were blocked by the histamine H-1 receptor antagonist mepyramine but not the histamine H-2 receptor antagonist zolantidine. Blockade of the 5-HT reuptake system by fluoxetine did not prevent histamine-induced decreases in 5-HT concentrations suggesting that histamine is not transported into nerve terminals via the 5-HT reuptake system to subsequently displace 5-HT stores. These data suggest that exogenous histamine increases 5-hydroxytryptaminergic neuronal activity through an action at histamine H-1 receptors. In contrast, neither the histamine H-3 receptor antagonist thioperamide, the histamine-N-methyltransferase inhibitor metoprine, nor combined thioperamide-metoprine treatment affected concentrations of 5-HT or 5-HIAA. suggesting these agents, which purportedly enhance endogenous histaminergic transmission, do not affect 5-hydroxytryptaminergic neuronal activity. These results reveal that procedures commonly employed to study central actions of histamine differentially affect 5-hydroxytryptaminergic neuronal activity in the rat hypothalamus.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 37 条
[1]   SEROTONIN - RELEASE IN FOREBRAIN BY STIMULATION OF MIDBRAIN RAPHE [J].
AGHAJANIAN, GK ;
ROSECRANS, JA ;
SHEARD, MH .
SCIENCE, 1967, 156 (3773) :402-+
[2]   HIGHLY POTENT AND SELECTIVE LIGANDS FOR HISTAMINE RECEPTORS-H-3 [J].
ARRANG, JM ;
GARBARG, M ;
LANCELOT, JC ;
LECOMTE, JM ;
POLLARD, H ;
ROBBA, M ;
SCHUNACK, W ;
SCHWARTZ, JC .
NATURE, 1987, 327 (6118) :117-123
[3]   ZOLANTIDINE (SK-AND-F-95282) IS A POTENT SELECTIVE BRAIN-PENETRATING HISTAMINE H-2-RECEPTOR ANTAGONIST [J].
CALCUTT, CR ;
GANELLIN, CR ;
GRIFFITHS, R ;
LEIGH, BK ;
MAGUIRE, JP ;
MITCHELL, RC ;
MYLEK, ME ;
PARSONS, ME ;
SMITH, IR ;
YOUNG, RC .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (01) :69-78
[4]  
CHAPIN DS, 1986, CURRENT SEP, V7, P68
[5]   ELEVATION OF BRAIN HISTAMINE LEVELS BY DIAMINOPYRIMIDINE INHIBITORS OF HISTAMINE N-METHYL TRANSFERASE [J].
DUCH, DS ;
BOWERS, SW ;
NICHOL, CA .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (10) :1507-1509
[6]   ROLE OF PRECURSOR AVAILABILITY IN CONTROL OF MONOAMINE BIOSYNTHESIS IN BRAIN [J].
FERNSTROM, JD .
PHYSIOLOGICAL REVIEWS, 1983, 63 (02) :484-546
[7]  
FINK K, 1990, N-S ARCH PHARMACOL, V342, P513
[8]  
FULLER RW, 1982, SEROTONIN BIOL PSYCH, P219
[9]  
FULLER RW, 1990, ANN NY ACAD SCI, V600, P68
[10]   EFFECTS OF HISTAMINE-H-3-RECEPTOR LIGANDS ON VARIOUS BIOCHEMICAL INDEXES OF HISTAMINERGIC NEURON ACTIVITY IN RAT-BRAIN [J].
GARBARG, M ;
TUONG, MDT ;
GROS, C ;
SCHWARTZ, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (01) :1-11